BackSimris Alg AB (publ) Overview

Simris Alg AB (publ) EBIT

Track Simris Alg AB (publ)'s EBIT ($-30M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$8.15M
↓ 13.88% YoY

As of Sep 30, 2026

Annual EBIT (TTM)

-$30.13M
↑ 0.82% YoY

Trailing 12 months ending Sep 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Simris Alg AB (publ) (SIMRIS-B.ST) FAQ

The latest EBIT for SIMRIS-B.ST is $-30M as of September 2026. That compares with $-30M in the prior-year period — up 0.8% year over year. That is below the Healthcare sector average of $1.1T. Investors often review this figure alongside Simris Alg AB (publ)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SIMRIS-B.ST's EBIT moved from $-30M to $-30M — a 0.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Simris Alg AB (publ)'s operating scale or balance-sheet position.

Against Healthcare companies, SIMRIS-B.ST currently prints $-30M for EBIT, while the sector average sits near $1.1T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Simris Alg AB (publ)'s growth, margins, and balance sheet.

A EBIT figure of $-30M for SIMRIS-B.ST is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $1.1T. Explore the charts below for those layers of context.

After noting SIMRIS-B.ST's EBIT ($-30M), review year-over-year change from $-30M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers